PPDC Sponsored Projects
Since its founding in 2013, the Pennsylvania Pediatric Medical Device Consortium (PPDC) has provided both guidance and seed funding for a range of pediatric products, including an airway clearance system, a powered arm brace, a speech-generating communication system, a vision acuity test for preverbal children, and a portable phototherapy device for newborns with neonatal jaundice. It has assisted more than 215 innovative projects and has awarded 42 seed grants of up to $50,000 each to companies in Pennsylvania and beyond. The Request For Applications for Sponsored Project Proposals is announced annually on the PMD Launchpad website.
Learn more about the projects the PPDC has helped to develop in our Advanced Device Registry.
Consortium Service Proposals
In addition to the annual round of seed grants, the PPDC accepts applications at all times for in-kind services and expert advice. If interested, please send a request to email@example.com for full instructions on how to apply.
Year round, the PPDC will offer mentoring services to all potential medical device developers from anywhere in the world. Upon receiving a mentoring request, the Consortium Leadership will form mentoring teams to address the unique needs of a particular innovator. We recognize that innovations do not necessarily come packaged, nor do inventors always know the steps involved in moving their innovations forward. Thus, our rigorous Step Zero Mentoring process will facilitate the development of excellent Consortium Service Proposals (CSP).
CSPs have no monetary budget submitted by the innovator, and no funds are transferred from the PPDC to the innovator or their company. Rather, the innovator submits a brief CSP for one or more Consortium Services in the PPDC network listed below:
- Bench testing
- Business planning
- Clinical trials
- Market research
- Regulatory advising
The PPDC resources and in-kind contributions from Consortium members are used to support the service provided, as well funds from the Innovator’s Institution or Company. CSPs are evaluated by the PPDC Regulatory Advisor, Seth Goldenberg, for commercial merit and to identify the regulatory pathway. Select Clinical & Scientific Advisory (CSAC) members also review the CSP for clinical and scientific merit.